Inhibitory effect of peptide prepared from corn gluten meal on 7,12- dimethylbenz[a]anthracene-induced mammary tumor progression in rats

Nutrition Research

Volumn 17, Issue 7, 1997, Pages 1121-1130

  Yamaguchi, Magoichi ^a   Takeuchi, Masayasu ^a   Ebihara, Kiyoshi ^b  

^a Fuji   (Japan)

^b EHIME UNIVERSITY   (Japan)

Author keywords

17 Estradiol; 7,12 Dimethylbenz a anthracene(DMBA); Corn peptide; Mammary tumor; Rat

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; AMINO ACID MIXTURE; CASEIN; GLUTEN; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER INCIDENCE; CANCER INHIBITION; CONTROLLED STUDY; CORN; DIETARY INTAKE; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030914153     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0271-5317(97)00083-3     Document Type: Article

References (26)

1. Graham S, Marshall J, Mettlin C, Rzepka T, Nemoto T, Byers T. Diet in the epidemiology of breast cancer. Am J Epidemiol 1982;116:68-75.
2. Goldin BR, Adlercreutz H, Gorbach SL, Woods MN, Dwyer JT, Conlon T, Bohn E, Gershoff SN. The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women. Am J Clin Nutr 1986;44:945-953.
3. Kritchevsky D. Nutrition and cancer. Cancer 1990;66:1321-1325.
4. Hawrylewicz EJ, Huang HH, Blair WH. Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats. J Nutr 1991;121: 1693-1698.
5. Barnes S, Grubbs C, Setchell KD, Carlson J. Soybeans inhibit mammary tumors in models breast cancer. In Mutagens and Carcinogenesis in the diet, pp. 239-253. (PariziaM, Aeschbacher HU, Felton JS, Sato S. editors) Wiley-Liss, New York, 1989.
6. Yamaguchi M, Takada M, Nozaki O, Ito M, Furukawa Y. Preparation of corn peptide from corn gluten meal and its administration effect on alcohol metabolism in stroke-prone spontaneously hypertensive rats. J Nutr Sei Vitaminol 1996;42:219-231.
7. American Institute of Nutrition. Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies. J Nutr 1977;107:1340-1348.5.
8. Lacroix A, Doskas C, Bhat PV. Inhibition of growth of established N-methyl-N-nitrosourea-induced mammary cancer in rats by retinoic acid and ovariectomy. Cancer Res 1990;50: 5731-5734.
9. Butcher RL, Collins WE, Fugo NW. Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17ß throughout the 4-day estrus cycle of the rat. Endocrinology 1974;94:1704-1708.
10. Breillout F, Hadida F, Echinard-Garvin P, Lascaux V, Poupon MF. Decreased rat rhabdomyosarcoma pulmonary metastasis in response to a low methionine diet. Anticancer Res 1987;7:861-868.
11. Shibata K. Basic Statistics for the Biologist, pp.64-78. Shobun Publishing, Tokyo, 1974.
12. Kritchevsky D, Weber MM, Klurfied DM. Dietary fat versus caloric content in initiation and promotion of 7,12-dimethylbenz(α)anthracene-induced mammary tumorigenesis in rats. Cancer Res 1984;44:3174-3177.
13. Carroll KK, Khor HT. Effects of level and type of dietary fat on incidence of mammary tumors induced in female Sprague-Dawley rats by 7,12-dimethylbenz(a) anthracene. Lopids 1971;6:415-420.
14. Hawrylewicz EJ, Huang HH, Kissane JQ, Drab EA. Enhancement of 7,12-dimethylbenz(a)anthracene(DMBA) mammary tumorigenesis by high dietary protein in rats. Nutr Rep Int 1982;26:807-820.
15. Clinton SK, Truex CR, Visek WJ. Dietary protein, aryl hydrocarbon hydroxylase and chemical carcinogenesis in rats. J Nutr 1979;109:55-62.
16. Carroll KK. Experimental Evidence of dietary factors and hormone-dependent cancers. Cancer Res 1975;35:3374-3383.
17. White FR, White J. Effect of a low lysine diet on mammary-tumor formation in strain C3H mice. J Natl Cancer Inst 1944;5:41-42.
18. Dunning WF, Curtis MR, Maun M. The effect of added dietary tryptophane on the occurrence of diethylstilbestrol-induced mammary cancer in rats. Cancer Res 1950;10:319-323.
19. Schaur RJ, Semmelrock HJ, Schreibmayer W, Tillian HM, Schauenstein E. Tumor host relations. V. Nitrogen metabolism in Yoshida sarcoma-bearing rats. Red uction of growth rate and increase of survival time by administration of physiological doses of branched-chain amino acids. J Cancer Res Clin Oncol 1980;97:285-293.
20. Crosby LE, Bistrian BR, Ling P, Istfan NW, Blackburn GL, Hoffman SB. Effects of branched chain amino acid-enriched total parenteral nutrition on amino acid utilization in rats bearing Yoshida sarcoma. Cancer Res 1988;48:2698-2702.
21. Davis SL. Plasma levels of prolactin, growth hormone, and insulin in sheep following the infusion of arginine, leucine and phenylalanine. Endocrinology 1972;91:549-555.
22. Blackard WG, Andrews SS, Lazarus EJ. Portal and peripheral vein immunoreactive glucagon concentrations after arginine or glucose infusion. Diabetes 1974;23:199-202.
23. Salter JM, Davidson IWF, Best CH. Effect of insulin and glucagon on tumor growth. Brit Med J 1958;2:5-7.
24. Takeda Y. Inhibitory effect of L-arginine on growth of rat mammary tumors induced by 7,12-Dimethylbenze(α)anthracene. Cancer Res 1975;35;2390-2393.
25. Adibi SA, Soleimanpour MR. Functional characterization of dipeptide transport system in human jejunum. J Clin Invest 1974;53:1368-1374.
26. Clarke EF, Lewis A, Waterhouse C. Peripheral amino acid levels in patients with cancer. Cancer 1980;42:2902-2913.